ALPHA-SYNUCLEIN KINASE

Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase. Cette invention concerne des agents et des méthodes de traitement de maladies associées avec la démence à corps de Lewy (...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ANDERSON, JOHN P, BANDUCCI, KELLY, BASI, GURIQBAL S, CHEREAU, DAVID, FRIGNON, NORMAND, L., JR, CHILCOTE, TAMIE J, GOLDSTEIN, JASON, GRISWOLD-PRENNER, IRENE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	ANDERSON, JOHN P BANDUCCI, KELLY BASI, GURIQBAL S CHEREAU, DAVID FRIGNON, NORMAND, L., JR CHILCOTE, TAMIE J GOLDSTEIN, JASON GRISWOLD-PRENNER, IRENE
description	Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase. Cette invention concerne des agents et des méthodes de traitement de maladies associées avec la démence à corps de Lewy (LBD) du cerveau d'un patient. Les inhibiteurs de PLK2 kinase constituent des agents préférés.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2009103010A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2009103010A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2009103010A33</originalsourceid><addsrcrecordid>eNrjZBBz9AnwcNQNjvQLdfZx9fRT8Pb0cwx25WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgYGloYGxgaGBo7GxsSpAgAwtB_5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ALPHA-SYNUCLEIN KINASE</title><source>esp@cenet</source><creator>ANDERSON, JOHN P ; BANDUCCI, KELLY ; BASI, GURIQBAL S ; CHEREAU, DAVID ; FRIGNON, NORMAND, L., JR ; CHILCOTE, TAMIE J ; GOLDSTEIN, JASON ; GRISWOLD-PRENNER, IRENE</creator><creatorcontrib>ANDERSON, JOHN P ; BANDUCCI, KELLY ; BASI, GURIQBAL S ; CHEREAU, DAVID ; FRIGNON, NORMAND, L., JR ; CHILCOTE, TAMIE J ; GOLDSTEIN, JASON ; GRISWOLD-PRENNER, IRENE</creatorcontrib><description>Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase. Cette invention concerne des agents et des méthodes de traitement de maladies associées avec la démence à corps de Lewy (LBD) du cerveau d'un patient. Les inhibiteurs de PLK2 kinase constituent des agents préférés.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091105&DB=EPODOC&CC=WO&NR=2009103010A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091105&DB=EPODOC&CC=WO&NR=2009103010A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANDERSON, JOHN P</creatorcontrib><creatorcontrib>BANDUCCI, KELLY</creatorcontrib><creatorcontrib>BASI, GURIQBAL S</creatorcontrib><creatorcontrib>CHEREAU, DAVID</creatorcontrib><creatorcontrib>FRIGNON, NORMAND, L., JR</creatorcontrib><creatorcontrib>CHILCOTE, TAMIE J</creatorcontrib><creatorcontrib>GOLDSTEIN, JASON</creatorcontrib><creatorcontrib>GRISWOLD-PRENNER, IRENE</creatorcontrib><title>ALPHA-SYNUCLEIN KINASE</title><description>Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase. Cette invention concerne des agents et des méthodes de traitement de maladies associées avec la démence à corps de Lewy (LBD) du cerveau d'un patient. Les inhibiteurs de PLK2 kinase constituent des agents préférés.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBz9AnwcNQNjvQLdfZx9fRT8Pb0cwx25WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgYGloYGxgaGBo7GxsSpAgAwtB_5</recordid><startdate>20091105</startdate><enddate>20091105</enddate><creator>ANDERSON, JOHN P</creator><creator>BANDUCCI, KELLY</creator><creator>BASI, GURIQBAL S</creator><creator>CHEREAU, DAVID</creator><creator>FRIGNON, NORMAND, L., JR</creator><creator>CHILCOTE, TAMIE J</creator><creator>GOLDSTEIN, JASON</creator><creator>GRISWOLD-PRENNER, IRENE</creator><scope>EVB</scope></search><sort><creationdate>20091105</creationdate><title>ALPHA-SYNUCLEIN KINASE</title><author>ANDERSON, JOHN P ; BANDUCCI, KELLY ; BASI, GURIQBAL S ; CHEREAU, DAVID ; FRIGNON, NORMAND, L., JR ; CHILCOTE, TAMIE J ; GOLDSTEIN, JASON ; GRISWOLD-PRENNER, IRENE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2009103010A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2009</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ANDERSON, JOHN P</creatorcontrib><creatorcontrib>BANDUCCI, KELLY</creatorcontrib><creatorcontrib>BASI, GURIQBAL S</creatorcontrib><creatorcontrib>CHEREAU, DAVID</creatorcontrib><creatorcontrib>FRIGNON, NORMAND, L., JR</creatorcontrib><creatorcontrib>CHILCOTE, TAMIE J</creatorcontrib><creatorcontrib>GOLDSTEIN, JASON</creatorcontrib><creatorcontrib>GRISWOLD-PRENNER, IRENE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANDERSON, JOHN P</au><au>BANDUCCI, KELLY</au><au>BASI, GURIQBAL S</au><au>CHEREAU, DAVID</au><au>FRIGNON, NORMAND, L., JR</au><au>CHILCOTE, TAMIE J</au><au>GOLDSTEIN, JASON</au><au>GRISWOLD-PRENNER, IRENE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ALPHA-SYNUCLEIN KINASE</title><date>2009-11-05</date><risdate>2009</risdate><abstract>Agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient are provided. Preferred agents include inhibitors of PLK2 kinase. Cette invention concerne des agents et des méthodes de traitement de maladies associées avec la démence à corps de Lewy (LBD) du cerveau d'un patient. Les inhibiteurs de PLK2 kinase constituent des agents préférés.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2009103010A3
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
title	ALPHA-SYNUCLEIN KINASE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T03%3A18%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANDERSON,%20JOHN%20P&rft.date=2009-11-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2009103010A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true